Evidence map›Paper›PMID 42036683›Full record

ArticleGenome biology2026

Highly efficient chromatin conformation capture with post-enrichment in single cells by HiChew.

Zhichao Chen, Yeming Xie, Chen Zhang, Chen Tan, Fengying Ruan, Wenfang Chen, Meng Luo, Mei Guo, Zhe Xie, Huimin Cao and 4 more

Abstract read
In one paragraph

Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zhichao Chen *College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
Yeming Xie *BGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Chen ZhangBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Chen TanBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Fengying RuanBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Wenfang ChenBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Meng LuoBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Mei GuoBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Zhe XieBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Huimin CaoBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Meifang TangBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China.
Xiuqing ZhangCollege of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
Ying ZhangNHC Key Laboratory of Male Reproduction and Genetics, Guangzhou, 510600, China. yingzhang@gdszjk.org.cn.
Chong TangBGI Genomics, BGI-Shenzhen, Shenzhen, 518083, China. tangchong@bgi.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present HiChew, a novel chromatin conformation capture method combining efficient sticky-end ligation with post-PCR methylation-based enrichment. HiChew achieves approximately 50% valid pair ratios compared to 8% for unenriched methods, while maintaining high sensitivity. Its single-cell implementation, snHiChew, achieves 45-50% valid pair ratios, and enables 5-10 kb resolution mapping with 70-80% bin coverage. Comparative analyses show strong concordance with conventional Hi-C for chromatin compartments, TADs, and loops. By combining scalability, cost-effectiveness and data quality, HiChew provides a powerful platform for advancing studies of 3D genome architecture analysis.

Indexed as

ChromatinSingle-Cell AnalysisAnimalsDNA MethylationHumansChromatin3D genome structureChromatin conformation captureChromatin interactionsDNA methylationHiChewHigh-throughput sequencingNuclear architecturePost-enrichment methodSingle-cell Hi-CValid pair ratio

Identifiers

PMID42036683
PMCPMC13112749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.